Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

绒促卵泡激素α N01注射液 - NMPA Drug Approval Details

Approvals/NMPA/Corifollitropin alfa N01 Injection

Approved

生物制品

Corifollitropin alfa N01 Injection

苏州晟济药业有限公司🇨🇳 National Medical Products Administration

Approval Date: Aug 19, 2025
Approval ID: 8mD84sStrQN
Company: 苏州晟济药业有限公司
Type: 生物制品

Approval Details

Approval Id: 8mD84sStrQN
Approval Number: 国药准字S20250049
Generic Name: 绒促卵泡激素α N01注射液
Generic Name En: Corifollitropin alfa N01 Injection
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 预充式注射器装：100μg（0.5ml）/支
Reg Date: 2025-08-19
Company Name: 苏州晟济药业有限公司
Company Address: 苏州工业园区星湖街218号生物纳米园C13楼301B单元
Production Company Name: 上海宝济药业股份有限公司
Production Company Address: 上海市宝山区罗新路28号
Company Detail Path: /organization/su-zhou-cheng-ji-yao-ye-you-xian-gong-si
Production Company Detail Path: /organization/bao-pharma-b

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 19, 2025

Approval ID

8mD84sStrQN

Type

生物制品

Back to NMPA Approvals